At present, the accurate diagnostic of NAFLD and NASH should remain is the biopsy, although the serum biomarker such as ALT level could be as a significant reference, but it should not be regarded as the diagnostic standard for the NAFLD and NASH [24, 26, 27]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.